---
title: Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory
  B-cell lymphomas.
date: '2023-12-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38048694
source: Trending page - PubMed
description: <span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Schuster+SJ&amp;cauthor_id=38048694"
  ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link"
  data-ga-label="Stephen J Schuster">Stephen J Schuster</a><sup class="affiliation-links"><span
  class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="Lymphoma
  Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania,
  United States." href="https://pubmed.ncbi.nlm.nih.gov/38048694#full-view-affiliation-1"
  ref="linksrc=author_af ...
disable_comments: true
---
<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Schuster+SJ&amp;cauthor_id=38048694" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="Stephen J Schuster">Stephen J Schuster</a><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States." href="https://pubmed.ncbi.nlm.nih.gov/38048694#full-view-affiliation-1" ref="linksrc=author_af ...